Pancreatic Cancer: A Neglected Disease Despite Recent Focus

As the world mourns Steve Jobs' passing, attention is drawn to the disease he publicly battled: neuroendocrine pancreatic cancer. Unlike the more common and aggressive adenocarcinoma, Jobs' tumor had a five-year survival rate of 50% to 80%. However, the lack of awareness and funding for pancreatic cancer research is alarming. Experts say it's a complicated disease that requires a concerted effort to develop effective treatments and improve patient outcomes.

Key Takeaways:

• Pancreatic cancer is the fourth-leading cause of death from cancer in the United States, with a lifetime risk of developing it being about 1 in 71.
• There are two types of pancreatic cancer: exocrine tumors (adenocarcinoma) and endocrine tumors (neuroendocrine tumors), with the latter being a rare form of the disease.
• The five-year survival rate for neuroendocrine tumors can range from 50% to 80%, compared to less than 5% for adenocarcinoma.
• Two new drugs, everolimus and sunitinib malate, have been approved for the treatment of pancreatic neuroendocrine tumors, but come with serious potential side effects.
• Researchers are working on developing targeted nanoparticle therapies and biomarkers for pancreatic cancer, with the aim of improving treatment options and patient outcomes.
• Genetic syndromes, such as MEN1 and VHL, can increase the risk of pancreatic neuroendocrine tumors, but the relationship between family history and pancreatic cancer risk is unclear.

Statistics:

• In 2023, about 44,030 people will be diagnosed with pancreatic cancer, and the disease will kill about 37,660 people, according to the American Cancer Society.
• The risk of developing pancreatic cancer increases with age, with most patients being older than 45 and nearly 90% over 55.
• The average age at diagnosis is 72, with men having a slightly higher likelihood of developing pancreatic cancer than women.
• African-Americans are more likely to develop pancreatic cancer than whites, with unknown reasons contributing to this association.

Sources:

• Elizabeth Landau, CNN, "Pancreatic Cancer: A Neglected Disease Despite Recent Focus"
• American Cancer Society, "Pancreatic Cancer Facts"
• National Cancer Institute, "Pancreatic Cancer Treatment"
• Mayo Clinic, "Neuroendocrine Tumors of the Pancreas"
• Cleveland Clinic, "Pancreatic Cancer: Symptoms, Diagnosis, and Treatment"